Skip to main content
. 2022 May 9;13:229–241. doi: 10.2147/JBM.S354526

Table 3.

Self-Reported Clinical Characteristics from Follow-Up Survey

Variable Total (N=57) Age 40–49 Years (N=20, 35.1%) Age ≥50 Years (N=37, 64.9%) P Valuea
Self-reported joint pain 0.08
 No pain 7 (12.3) 4 (20.0) 3 (8.1)
 Any pain 50 (87.7) 16 (80.0) 34 (91.9)
  Some of time even if not bleeding 19 (33.3) 9 (45.0) 10 (27.0)
  Most of time even not bleeding 21 (36.8) 3 (15.0) 18 (48.6)
  Severe pain 10 (17.5) 4 (20.0) 6 (16.2)
Joint range of motion limitation 0.69
 No limitation 11 (19.6) 5 (26.3) 6 (16.2)
 Any limitation 45 (80.4) 14 (73.7) 31 (83.8)
  When bleeding 2 (3.6) 1 (5.3) 1 (2.7)
  When not bleeding 34 (60.7) 11 (57.9) 23 (62.2)
  Severe limitation 9 (16.1) 2 (10.5) 7 (18.9)
Number of joint bleeds 1.5 (2.3) 1.8 (2.7) 1.3 (2.0) 0.44
Number of non-joint bleeds 0.6 (1.3) 0.4 (0.7) 0.7 (1.5) 0.30
Depression measured by PHQ-9 0.85
 Mild, 5–9 8 (14.3) 3 (15.0) 5 (13.9)
 Diagnostic depression, ≥10 58 (85.7) 17 (85.0) 31 (86.1)
  Moderate, 10–14 26 (46.4) 9 (45.0) 17 (47.2)
  Moderately severe, 15–19 17 (30.4) 7 (35.0) 10 (27.8)
  Severe depression, 20–27 5 (8.9) 1 (5.0) 4 (11.1)
Anxiety measured by GAD7 0.81
 Mild, 5–9 36 (64.3) 12 (60.0) 24 (66.7)
 Diagnostic anxiety, ≥10 20 (35.7) 8 (40.0) 12 (33.3)
  Moderate, 10–14 14 (25.0) 6 (30.0) 8 (22.2)
  Severe, 15–21 6 (10.7) 2 (10.0) 4 (11.1)

Notes: Data were presented as number (column percentage). aP values were calculated from chi-square tests.